Umbelliferone

Umbelliferone

SCHEMBL2767044

O=c1ccc2ccc(O)cc2o1.[KH]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 11/20 0.96
CA12 O43570 10/20 0.96
MCL1 Q07820 7/20 0.96
KDM4E B2RXH2 7/20 0.96
ALDH1A1 P00352 6/20 0.96
AKR1B1 P15121 6/20 0.96
GLA P06280 6/20 0.96
GAA P10253 6/20 0.96
CA1 P00915 6/20 0.96
HPGD P15428 5/20 0.96
HSD17B10 Q99714 5/20 0.96
CASP1 P29466 4/20 0.96
CASP7 P55210 4/20 0.96
ERAP1 Q9NZ08 3/20 0.96
KMT2A Q03164 3/20 0.96
TDP1 Q9NUW8 3/20 0.96
MEN1 O00255 2/20 0.96
LMNA P02545 3/20 0.62
CYP1A2 P05177 3/20 0.62
PTGS1 P23219 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Umbelliferone SCHEMBL29396070 0.98 CA9 (1.00) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL11137587 0.98 CA9 (1.00) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL29624448 0.98 CA9 (1.00) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL22018 0.98 CA9 (1.00) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL27915972 0.96 CA9 (0.96) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL27427599 0.96 CA9 (0.96) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL27700116 0.96 CA9 (0.96) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL307982 0.96 CA9 (0.96) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL29001874 0.94 CA9 (0.92) CA9CA12MCL1KDM4EALDH1A1
Umbelliferone SCHEMBL27896245 0.94 CA9 (0.92) CA9CA12MCL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1260508-B1 REAGENTS FOR THE QUANTITATION OF ACTIVE OXYGEN SEKISUI MEDICAL CO LTD (JP) 2010-04-14 EP disclosed
US-7087766-B2 Reagents for the quantitation of active oxygen DAIICHI PURE CHEMICALS CO., LTD. (JP) 2006-08-08 US disclosed
US-20030153027-A1 Reagents for the quantitation of active oxygen SEKISUI MEDICAL CO., LTD. (JP) 2003-08-14 US disclosed
EP-1260508-A1 REAGENTS FOR THE QUANTITATION OF ACTIVE OXYGEN DAIICHI PURE CHEMICALS CO., LTD. (JP) 2002-11-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153027-A1 Reagents for the quantitation of active oxygen CBR1, LPO, CBR3 CA9 491/4885CA12 706/4885MCL1 2802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.